Drug Type Mesenchymal stem cell therapy |
Synonyms Autologous bone marrow derived mesenchymal stem cells |
Target- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute myocardial infarction | Phase 3 | KR | 01 Sep 2013 |
NCT02344849 (Pubmed) Manual | Phase 1 | 10 | (post-prostatectomy ED) | wbjfbmuyfy(wyhitdxyni) = troefdrxka yeshnerhpp (nahetzbbtq ) View more | Positive | 01 Oct 2021 | |
(DM-associated ED) | wbjfbmuyfy(kddtzirtwc) = koseyvxjhw mtbreebqgc (ztsvvyfnzd ) View more |